Rong Wang

Dr. Rong Wang

Xuanwu Hospital, Capital Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Brain Research Bulletin
Verified
Journal Article
Closed access
PSPenghui Song
Penghui Song
THTao Han
Tao Han
HLHua Lin
Hua Lin
SLSiran Li
Siran Li
QHQian Huang
Qian Huang
YWYuping Wang
Yuping Wang

11 July 2023 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
RWRong Wang
Rong Wang
HNHan Na
Han Na
SCShaowen Cheng
Shaowen Cheng
YZYanglin Zheng
Yanglin Zheng
JYJiangling Yao
Jiangling Yao
YGYuntao Gu
Yuntao Gu
Osteoporosis is a common disease characterized by reduced bone mass, microstructural deterioration, fragility and consequent fragility fractures and is particularly prevalent among the elderly population. Although glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs) have positive effects on bones, their role in the prevention of osteoporotic fractures remains to be elucidated. The present study assigned female Sprague Dawley rats with osteoporotic fractures into variectomized osteoporosis (OVX), OVX + liraglutide (LIRA) (50 µg/kg/day subcutaneous LIRA) and control groups. At 3 and 6 weeks postoperatively, X‑ray, tartrate‑resistant acid phosphatase (TRAP) staining, histological and biomechanical assays and assessment of femoral bone mineral density (BMD) were performed. Compared with the OVX group, GLP‑1 RA treatment improved the formation of calluses and osseous union. TRAP staining showed significantly fewer osteoclasts in the OVX + LIRA group compared with the OVX group. In the osteoporotically fractured rats, LIRA improved bone strength at the femoral diaphysis, stiffness, ultimate load and femoral trabecular BMD Compared with the OVX group. GLP‑1 RA treatment inhibited osteoclast formation and improved trabecular bone architecture and mass in osteoporotic fracture model rats, leading to improved biomechanical strength. GLP‑1 RAs may be used as novel anti‑osteoporotic fracture agents.

15 October 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
YLYuxia Li
Yuxia Li
MKMeimei Kang
Meimei Kang
HWHongxing Wang
Hongxing Wang
HJHe Jin
He Jin
XWXiaozhen Wang
Xiaozhen Wang
HYHan ying
Han ying
Subjective cognitive decline (SCD) is a risk factor for Alzheimer’s disease (AD). Urinary Alzheimer-associated neuronal thread protein (AD7c-NTP) has been identified as a biomarker for AD. It was hypothesized that if urinary AD7c-NTP were also elevat

1 May 2021 in Clinical Neurophysiology
Verified
Journal Article
Closed access
PSPenghui Song
Penghui Song
SLSiran Li
Siran Li
WHWensi Hao
Wensi Hao
MWMin Wei
Min Wei
JLJianghong Liu
Jianghong Liu
YWYuping Wang
Yuping Wang

12 December 2023 in Brain Research
Verified
Journal Article
Closed access
XWXiaozhen Wang
Xiaozhen Wang
WGWenjing Gan
Wenjing Gan
MKMeimei Kang
Meimei Kang
CLCaizhen Lv
Caizhen Lv
ZZZhiwei Zhao
Zhiwei Zhao
RWRong Wang
Rong Wang

31 July 2020 in Aging
Verified
Journal Article
Open access
YLYuxia Li
Yuxia Li
SGShaochen Guan
Shaochen Guan
HJHe Jin
He Jin
HLHongjun Liu
Hongjun Liu
MKMeimei Kang
Meimei Kang
RWRong Wang
Rong Wang
Urinary Alzheimer-associated neuronal thread protein (AD7c-NTP) is elevated in early Alzheimer's disease (AD) and mild cognitive impairment, and is considered a biomarker for the early diagnosis of AD. However, it has not yet been investigated whether urinary AD7c-NTP is elevated with increases in blood biochemical indicators related to AD risk factors. We recruited 2180 participants, aged 35–93 years, from communities of four districts in Beijing. Blood biochemical indicators, including blood glucose, blood lipids, renal function, and high-sensitivity C-reactive protein, were measured using routine methods. Urinary AD7c-NTP was detected using an enzyme-linked immunosorbent assay AD7c-NTP kit. In the general population, there were no significant differences in urinary AD7c-NTP levels in subjects with different Mini–Mental State Examination levels or C-reactive protein values. After adjusting for age and sex, there were significant differences in urinary AD7c-NTP levels between different education levels, marital statuses, blood glucose, blood lipids, and kidney function. There was a negative correlation between urinary AD7c-NTP levels and serum creatinine (r = –0.128). There was a positive correlation between urinary AD7c-NTP levels and HbA1c (r = 0.104), insulin (r = 0.101), and triglycerides (r = 0.093). Urinary AD7c-NTP might be useful as a potential indicator to predict AD risk.